Tag: UK Pharma

UK Government Invests £3.5m to Help Develop New Antibitoic Treatments for Gonorrhoea

The UK government has announced that it is to invest £3.5 million to help develop new treatments for gonorrhoea and make them available to low- and middle-income countries. The investme...

UK Plans to Loosen Rules on Low-Risk Clinical Trials in Post-Brexit Shakeup

uk
The United Kingdom government has proposed relaxing the regulatory requirements on the lowest risk clinical trials after it leaves the European Union. Officials made the proposal in a suite of changes...

UK’s Competition Watchdog Uncovered Illegal Agreement, Resulting in Huge Price Hikes

The UK’s competition watchdog has provisionally found three drug firms signed an illegal agreement, resulting in huge price hikes for an essential medicine used by the NHS. The Competition and Mark...

Procarta Announced Award to Progress Pipeline of Antibiotic Precision Meds

Procarta Biosystems, a privately held UK-based biotech company, announced a CARB-X award of up to $9.2 million to progress its pipeline of antibiotic precision medicines. The award includes initial no...

Meds Could Be Delayed Up to 6 Months in Worst Brexit Scenario

Medicine and medical product supply chains could experience “severe extended delays” for up to six months in the “worst case” scenario after the UK leaves the EU, according to a government report. ...

UK Government Invests over £130 mln to Tackle Serious Diseases

The UK government has announced an investment of over £130 million for new tech to tackle cancer and debilitating illnesses. The news means that thousands of NHS patients could receive faster diagn...

ABPI and NHS to Launch New Guidance for Joint Working

The Association of the British Pharmaceutical Industry (ABPI) has launched a new guidance for joint working between the NHS and industry, which sets out a ten-step process to scope, set up and monitor...

No-Deal Brexit Could “Devastate” NHS, Health Leaders Warn

A no-deal Brexit could “devastate” the NHS by disrupting the supply of life-saving medicine by up to six months, health leaders have warned. The British Medical Association, Royal College of Nursin...

£267,000 Grant for Cell Therapy Stabilisation Technologies

Atelerix Consortium awarded £267,000 Innovate UK Grant for collaboration with the Cell and Gene Therapy Catapult and Rexgenero on cell therapy stabilisation technologies. Rexgenero, a regenerative me...

HRT Shortage in UK to Continue Next Year

Around half of HRT products have been reported as out of stock in UK pharmacies due to supply issues in China, leading to a shortage. A shortage of hormone replacement therapy (HRT) in the UK has l...

Possible Meds Shortage in No-Deal Brexit Case

Leaked government documents have revealed that a no-deal Brexit will result in medicine shortages. The Operation Yellowhammer dossier indicates that fewer drug imports could be a reality for the UK. ...

Cancer Research Convergence Science Centre Launched in UK

As part of the new £13 million Cancer Research UK Convergence Science Centre at The Institute of Cancer Research, scientists are “re-imagining ultrasound technology to develop a treatment that can liq...

AstraZeneca’s Lynparza to be Funded through UK’s Cancer Drugs Fund

astrazeneca
A "game-changing" ovarian cancer drug that can extend lives by delaying or even preventing the disease recurring is now being made available on the NHS. Lymparza (olaparib) could offer a cure for some...

MHRA to Issue Guidance for UK Manufacturers in No-Deal Case

If Boris Johnson is named the new UK Prime Minister, many will regard the chance of a no-deal Brexit as an uncomfortably real possibility. Drugmakers need to prepare accordingly, and the UK’s Medic...

Boys in UK Will Be Offered Free HPV Vaccine

In a bid to reduce the number of cancer cases in the UK, boys will be offered the Human Papilloma Virus (HPV), the government has announced. From September this year, boys in year 8 will be offered...

Pharma Invests £377m in UK R&D Collaborations, New ABPI Figures Showed

New figures published by the ABPI show that pharma invests £377m in UK R&D collaborations, working with healthcare professionals and organisations to improve care for NHS patients. The data pub...